Novartis Venture Fund extends its strategic and geographic reach
Integration of the Novartis BioVenture Fund strengthens its position in the USA
22-Feb-2002 -
Basel, 21 February 2002 – In its fifth year, the Novartis Venture Fund extended its role as an important partner for start-up companies in Switzerland and other countries, as illustrated in the Activity Report published today. To date, the Fund has been involved in the establishment of 107 ...
biotechnology
collaborations
diseases
+5